Research ExplorerPublicationsReduced-intensity conditioning allogeneic stem cell transpla...

Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience.

Standard

Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience. / Le Gouill, S; Kröger, Nicolaus; Dhedin, N; Nagler, A; Bouabdallah, K; Yakoub-Agha, I; Kanouni, T; Bulabois, C E; Tournilhac, O; Buzyn, A; Rio, B; Moles, M P; Shimoni, A; Bacher, Ulrike; Ocheni, Sunday; Milpied, N; Harousseau, J L; Moreau, P; Leux, C; Mohty, M.

In: ANN ONCOL, Vol. 23, No. 10, 10, 01.10.2012, p. 2695-2703.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Le Gouill, S, Kröger, N, Dhedin, N, Nagler, A, Bouabdallah, K, Yakoub-Agha, I, Kanouni, T, Bulabois, CE, Tournilhac, O, Buzyn, A, Rio, B, Moles, MP, Shimoni, A, Bacher, U, Ocheni, S, Milpied, N, Harousseau, JL, Moreau, P, Leux, C & Mohty, M 2012, 'Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience.', ANN ONCOL, vol. 23, no. 10, 10, pp. 2695-2703. https://doi.org/10.1093/annonc/mds054

APA

Le Gouill, S., Kröger, N., Dhedin, N., Nagler, A., Bouabdallah, K., Yakoub-Agha, I., Kanouni, T., Bulabois, C. E., Tournilhac, O., Buzyn, A., Rio, B., Moles, M. P., Shimoni, A., Bacher, U., Ocheni, S., Milpied, N., Harousseau, J. L., Moreau, P., Leux, C., & Mohty, M. (2012). Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience. ANN ONCOL, 23(10), 2695-2703. [10]. https://doi.org/10.1093/annonc/mds054

Vancouver

Le Gouill S, Kröger N, Dhedin N, Nagler A, Bouabdallah K, Yakoub-Agha I et al. Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience. ANN ONCOL. 2012 Oct 1;23(10):2695-2703. 10. https://doi.org/10.1093/annonc/mds054

Bibtex

@article{c3c37e81f8ac4224ab3bad83964e5eb0,
title = "Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience.",
abstract = "Despite therapeutic approach that combines rituximab-containing chemotherapy, followed or not by autologous stem cell transplantation (auto-SCT), mantle cell lymphoma (MCL) patients experience relapses. Reduced-intensity conditioning allogeneic stem cell transplantation (RIC-allo-SCT) at time of relapse may represent an attractive strategy.",
keywords = "Adult, Humans, Male, Aged, Female, Middle Aged, Retrospective Studies, Recurrence, *Stem Cell Transplantation, Lymphoma, Mantle-Cell/*surgery, *Transplantation Conditioning, Adult, Humans, Male, Aged, Female, Middle Aged, Retrospective Studies, Recurrence, *Stem Cell Transplantation, Lymphoma, Mantle-Cell/*surgery, *Transplantation Conditioning",
author = "{Le Gouill}, S and Nicolaus Kr{\"o}ger and N Dhedin and A Nagler and K Bouabdallah and I Yakoub-Agha and T Kanouni and Bulabois, {C E} and O Tournilhac and A Buzyn and B Rio and Moles, {M P} and A Shimoni and Ulrike Bacher and Sunday Ocheni and N Milpied and Harousseau, {J L} and P Moreau and C Leux and M Mohty",
year = "2012",
month = oct,
day = "1",
doi = "10.1093/annonc/mds054",
language = "English",
volume = "23",
pages = "2695--2703",
journal = "ANN ONCOL",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "10",

}

RIS

TY - JOUR

T1 - Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience.

AU - Le Gouill, S

AU - Kröger, Nicolaus

AU - Dhedin, N

AU - Nagler, A

AU - Bouabdallah, K

AU - Yakoub-Agha, I

AU - Kanouni, T

AU - Bulabois, C E

AU - Tournilhac, O

AU - Buzyn, A

AU - Rio, B

AU - Moles, M P

AU - Shimoni, A

AU - Bacher, Ulrike

AU - Ocheni, Sunday

AU - Milpied, N

AU - Harousseau, J L

AU - Moreau, P

AU - Leux, C

AU - Mohty, M

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Despite therapeutic approach that combines rituximab-containing chemotherapy, followed or not by autologous stem cell transplantation (auto-SCT), mantle cell lymphoma (MCL) patients experience relapses. Reduced-intensity conditioning allogeneic stem cell transplantation (RIC-allo-SCT) at time of relapse may represent an attractive strategy.

AB - Despite therapeutic approach that combines rituximab-containing chemotherapy, followed or not by autologous stem cell transplantation (auto-SCT), mantle cell lymphoma (MCL) patients experience relapses. Reduced-intensity conditioning allogeneic stem cell transplantation (RIC-allo-SCT) at time of relapse may represent an attractive strategy.

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Retrospective Studies

KW - Recurrence

KW - Stem Cell Transplantation

KW - Lymphoma, Mantle-Cell/surgery

KW - Transplantation Conditioning

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Retrospective Studies

KW - Recurrence

KW - Stem Cell Transplantation

KW - Lymphoma, Mantle-Cell/surgery

KW - Transplantation Conditioning

U2 - 10.1093/annonc/mds054

DO - 10.1093/annonc/mds054

M3 - SCORING: Journal article

C2 - 22440229

VL - 23

SP - 2695

EP - 2703

JO - ANN ONCOL

JF - ANN ONCOL

SN - 0923-7534

IS - 10

M1 - 10

ER -